Graham Capital Management L.P. Decreases Position in GE HealthCare Technologies Inc. $GEHC

Key Points

• Graham Capital Management L.P. reduced its stake in GE HealthCare Technologies by 30%, now owning 14,713 shares worth approximately $1.2 million.
• Analysts have mixed ratings on GE HealthCare, with Morgan Stanley lowering their target price from $78 to $74, while Zacks upgraded it to a "strong-buy," indicating a generally optimistic outlook.
• GE HealthCare recently announced a quarterly dividend of $0.035 per share, reflecting an annual yield of 0.2% based on their current dividend payout ratio of 2.87%.

Graham Capital Management L.P. lowered its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 30.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,713 shares of the company's stock after selling 6,303 shares during the quarter. Graham Capital Management L.P.'s holdings in GE HealthCare Technologies were worth $1,187,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Alamea Verwaltungs GmbH acquired a new stake in GE HealthCare Technologies during the first quarter worth $497,000. DRW Securities LLC bought a new stake in GE HealthCare Technologies in the 1st quarter valued at $260,000. Baird Financial Group Inc. lifted its position in shares of GE HealthCare Technologies by 3.1% during the 1st quarter. Baird Financial Group Inc. now owns 183,226 shares of the company's stock valued at $14,788,000 after acquiring an additional 5,447 shares during the period. Pinnacle Wealth Planning Services Inc. acquired a new position in GE HealthCare Technologies in the 1st quarter worth about $200,000. Finally, Kingdon Capital Management L.L.C. acquired a new stake in GE HealthCare Technologies during the first quarter worth approximately $7,869,000. Hedge funds and other institutional investors own 82.06% of the company's stock.

Analysts Set New Price Targets

Several research analysts recently issued reports on the company. Citigroup lifted their target price on GE HealthCare Technologies from $89.00 to $93.00 and gave the company a "buy" rating in a research report on Thursday, July 31st. Morgan Stanley cut their target price on GE HealthCare Technologies from $78.00 to $74.00 and set an "equal weight" rating on the stock in a research report on Thursday, July 31st. Zacks Research upgraded GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a report on Thursday, August 28th. Wall Street Zen upgraded GE HealthCare Technologies from a "hold" rating to a "buy" rating in a report on Saturday, May 31st. Finally, BTIG Research reiterated a "buy" rating on shares of GE HealthCare Technologies in a report on Monday, July 14th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat.com, GE HealthCare Technologies has a consensus rating of "Moderate Buy" and a consensus price target of $88.55.

GE HealthCare Technologies Price Performance

Shares of GEHC stock traded up $2.34 during trading hours on Monday, hitting $78.07. The stock had a trading volume of 3,969,297 shares, compared to its average volume of 3,952,494. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The stock's 50-day moving average price is $74.28 and its two-hundred day moving average price is $73.89. The stock has a market capitalization of $35.64 billion, a price-to-earnings ratio of 15.99, a PEG ratio of 2.89 and a beta of 1.13. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.16 and a quick ratio of 0.93.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The business had revenue of $5 billion during the quarter, compared to analyst estimates of $4.96 billion. During the same quarter in the previous year, the business earned $1.00 earnings per share. The company's revenue for the quarter was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Equities analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 25th were issued a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend was Friday, July 25th. GE HealthCare Technologies's dividend payout ratio is presently 2.87%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.